Boehringer Ingelheim International Gmbh

Spain

All drugs from this manufacturer

  • ACTILYSE POWDER AND SOLVENT FOR SOLUTION FOR INJECTION AND FOR INFUSION

    It is used to treat diseases caused by blood clots in the blood vessels, such as heart attacks (acute myocardial infarction), clots in the arteries of the lungs (massive acute pulmonary embolism), and strokes caused by a clot in a brain artery (acute ischemic stroke).

    Dosage form: powder and solvent for solution for injection and for infusion

    Active substance Dosage
    alteplase 10 mg

    ATC: B01A B01AD B01AD02

  • It is used to treat adult patients with a specific type of non-small cell lung cancer that has a mutation in the EGFR gene, either as a first-line treatment or if previous chemotherapy has not worked. It is also used in squamous cell carcinoma if previous chemotherapy has been insufficient.

    Dosage form: tablets, film-coated

    Active substance Dosage
    afatinib 20 mg

    ATC: L01E L01EB L01EB03

  • It is used to treat a specific type of non-small cell lung cancer in adults that presents a mutation in the EGFR gene, either as a first-line treatment or when chemotherapy has not worked. It is also used in squamous cell cases if previous chemotherapy has been insufficient.

    Dosage form: tablets, film-coated

    Active substance Dosage
    afatinib 30 mg

    ATC: L01E L01EB L01EB03

  • It is used to treat adult patients with a specific type of non-small cell lung cancer that has a mutation in the EGFR gene. It can be prescribed as a first-line treatment or when chemotherapy has not worked.

    Dosage form: tablets, film-coated

    Active substance Dosage
    afatinib 40 mg

    ATC: L01E L01EB L01EB03

  • It is used to treat type 2 diabetes in adults when the disease cannot be controlled with metformin and/or a sulfonylurea alone.

    Dosage form: tablets, film-coated

    Active substance Dosage
    empagliflozin 10 mg
    linagliptin 5 mg

    ATC: A10B A10BD A10BD19

  • It is used to treat type 2 diabetes in adults, either as an adjunct to other medications (metformin or sulfonylureas) or as an alternative to taking the active ingredients separately.

    Dosage form: tablets, film-coated

    Active substance Dosage
    empagliflozin 25 mg
    linagliptin 5 mg

    ATC: A10B A10BD A10BD19

  • It is used to treat type 2 diabetes in adults and children aged 10 years and older, heart failure in adults, and chronic kidney disease in adults. It also helps prevent heart disease in patients with type 2 diabetes.

    Dosage form: tablets, film-coated

    Active substance Dosage
    empagliflozin 10 mg

    ATC: A10B A10BK A10BK03

  • It is used to treat type 2 diabetes in adults and children aged 10 years and older, heart failure in adults, and chronic kidney disease in adults.

    Dosage form: tablets, film-coated

    Active substance Dosage
    empagliflozin 25 mg

    ATC: A10B A10BK A10BK03

  • It is used to control blood sugar levels in adults with type 2 diabetes mellitus. It helps improve insulin levels after meals and reduces the amount of sugar produced by the body.

    Dosage form: tablets, film-coated

    Active substance Dosage
    linagliptin 2,5 mg
    metformin hydrochloride 1000 mg

    ATC: A10B A10BD A10BD11

  • It is used to control blood sugar levels in adults with type 2 diabetes mellitus. It helps improve the effects of insulin after meals and reduces sugar production in the body.

    Dosage form: tablets, film-coated

    Active substance Dosage
    linagliptin 2,5 mg
    metformin hydrochloride 850 mg

    ATC: A10B A10BD A10BD11

  • It is used to treat myocardial infarctions (heart attacks) within 6 hours of the onset of symptoms, helping to dissolve blood clots in the blood vessels of the heart to prevent damage and save lives.

    Dosage form: powder and solvent for solution for injection

    Active substance Dosage
    tenecteplase 1000 U

    ATC: B01A B01AD B01AD11

  • It is used in adults to treat stroke caused by a blood clot in an artery in the brain (acute ischemic stroke), provided that less than 4.5 hours have passed since the last time symptoms were not present.

    Dosage form: powder for solution for injection

    Active substance Dosage
    tenecteplase 25 mg

    ATC: B01A B01AD B01AD11

  • It is used to treat myocardial infarctions (heart attacks) within 6 hours of the onset of symptoms, helping to dissolve blood clots in the heart vessels to prevent damage and save lives.

    Dosage form: powder and solvent for solution for injection

    Active substance Dosage
    tenecteplase 1000 U

    ATC: B01A B01AD B01AD11

  • It is used to treat high blood pressure (hypertension) in adults and to reduce the risk of suffering heart attacks or strokes in people with cardiovascular risk.

    Dosage form: tablets

    Active substance Dosage
    telmisartan 40 mg

    ATC: C09C C09CA C09CA07

  • It is used to treat high blood pressure (hypertension) in adults and to reduce the risk of suffering heart attacks or strokes in people with specific cardiovascular risk.

    Dosage form: tablets

    Active substance Dosage
    telmisartan 80 mg

    ATC: C09C C09CA C09CA07

  • It is used to treat high blood pressure (essential hypertension) in adults whose blood pressure is not adequately controlled with telmisartan alone.

    Dosage form: tablets

    Active substance Dosage
    telmisartan 40 mg
    hydrochlorothiazide 12,5 mg

    ATC: C09D C09DA C09DA07

  • It is used to treat high blood pressure (essential hypertension) in adults when the use of telmisartan alone is not sufficient to control it.

    Dosage form: tablets

    Active substance Dosage
    telmisartan 80 mg
    hydrochlorothiazide 12,5 mg

    ATC: C09D C09DA C09DA07

  • It is used to treat high blood pressure (essential hypertension) in adults when blood pressure is not adequately controlled with other doses or previous treatments.

    Dosage form: tablets

    Active substance Dosage
    telmisartan 80 mg
    hydrochlorothiazide 25 mg

    ATC: C09D C09DA C09DA07

  • It is used to treat the symptoms of idiopathic Parkinson's disease in adults (either alone or in combination with levodopa) and to treat the symptoms of moderate to severe idiopathic restless legs syndrome in adults.

    Dosage form: tablets

    Active substance Dosage
    pramipexol 0,18 mg

    ATC: N04B N04BC N04BC05

  • It is used to treat the symptoms of idiopathic Parkinson's disease in adults (either alone or in combination with levodopa) and to treat moderate to severe idiopathic restless legs syndrome in adults.

    Dosage form: tablets

    Active substance Dosage
    pramipexol 0,18 mg

    ATC: N04B N04BC N04BC05

  • It is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be taken alone or together with levodopa.

    Dosage form: tablets, prolonged-release

    Active substance Dosage
    pramipexol 0,26 mg

    ATC: N04B N04BC N04BC05

  • What is MIRAPEXIN used for?": "It is used to treat the symptoms of idiopathic Parkinson's disease in adults (either alone or in combination with levodopa) and to treat the symptoms of moderate to severe idiopathic restless legs syndrome in adults.", "How should I take MIRAPEXIN?": "The dose indicated by your doctor must be followed exactly. Tablets should be swallowed with water and may be taken with or without food. For Parkinson's disease, the dose is usually divided into 3 equal doses per day. For restless legs syndrome, the dose is typically taken once daily, in the evening, 2-3 hours before bedtime.", "When should I not take this medication?": "Do not take it if you are allergic to pramipexole or any of its components. Its use is also not recommended in children or adolescents under 18 years of age.", "What side effects can MIRAPEXIN cause?": "Very frequent side effects include involuntary movements (dyskinesia), drowsiness, dizziness, and nausea. Other common side effects are confusion, fatigue, insomnia, headache, blurred vision, constipation, or vomiting. Unusual behaviors or uncontrollable impulses (such as excessive gambling or uncontrollable spending) have also been reported.", "What should I keep in mind regarding other medications?": "You should avoid using MIRAPEXIN along with antipsychotic medications. Caution should be exercised if you use medications such as cimetidine, amantadine, mexiletine, zidovudine, cisplatin, quinine, or procainamide. If you are taking levodopa, it is recommended to decrease your dose when starting this treatment.", "What happens if I forget a dose or stop taking the medication?": "If you forget a dose, skip the missed dose and take the next one at the correct time; do not take a double dose. You should not abruptly discontinue treatment without consulting your doctor, as in Parkinson's disease this can be dangerous and cause serious symptoms such as muscle rigidity, fever, or confusion.", "Can I drive or use machines while taking this medication?": "You should exercise caution, as it may cause drowsiness, sudden sleep episodes, or hallucinations. If you experience any of these effects, you must not drive or operate machinery."}

    Dosage form: tablets

    Active substance Dosage
    pramipexol 0,7 mg

    ATC: N04B N04BC N04BC05

  • It is used to treat the symptoms of idiopathic Parkinson's disease in adults (either alone or in combination with levodopa) and to treat moderate to severe idiopathic restless legs syndrome in adults.

    Dosage form: tablets

    Active substance Dosage
    pramipexol 0,7 mg

    ATC: N04B N04BC N04BC05

  • It is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be taken alone or together with levodopa.

    Dosage form: tablets, prolonged-release

    Active substance Dosage
    pramipexol 1,05 mg

    ATC: N04B N04BC N04BC05

  • It is used to treat the symptoms of idiopathic Parkinson's disease in adults. It can be taken alone or together with levodopa.

    Dosage form: tablets, prolonged-release

    Active substance Dosage
    pramipexol 2,1 mg

    ATC: N04B N04BC N04BC05

  • It is used to reduce inflammation and pain in joints and muscles. It is prescribed for the short-term treatment of osteoarthritis flares and for the long-term treatment of rheumatoid arthritis and ankylosing spondylitis.

    Dosage form: tablets

    Active substance Dosage
    meloxicam 15 mg

    ATC: M01A M01AC M01AC06

  • It is used to reduce inflammation and pain in joints and muscles. It is indicated for the short-term treatment of osteoarthritis flares, and for the long-term treatment of rheumatoid arthritis and ankylosing spondylitis.

    Dosage form: tablets

    Active substance Dosage
    meloxicam 7,5 mg

    ATC: M01A M01AC M01AC06

  • It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, fibrosing interstitial lung diseases with a progressive phenotype in children and adolescents aged 6 to 17 years, and interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children aged 6 years and older. It helps reduce the progression of scarring and stiffening of the lungs.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 100 mg

    ATC: L01E L01EX L01EX09

  • It is used to treat idiopathic pulmonary fibrosis (IPF) in adults, other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype in adults, progressive fibrosing interstitial lung diseases in children and adolescents aged 6 to 17 years, and interstitial lung disease associated with systemic sclerosis in adults, adolescents, and children aged 6 years or older. It helps reduce the occurrence of new scarring and hardening of the lungs.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    nintedanib 150 mg

    ATC: L01E L01EX L01EX09

  • It is used in children to treat blood clots and to prevent them from forming again.

    Dosage form: granules, coated

    Active substance Dosage
    dabigatran etexilate mesylate 126,83 mg

    ATC: B01A B01AE B01AE07

  • It is used in adults to prevent the formation of blood clots following knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.

    Dosage form: capsules, hard

    Active substance Dosage
    dabigatran etexilate mesylate 110 mg

    ATC: B01A B01AE B01AE07

  • It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke and other clots in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.

    Dosage form: capsules, hard

    Active substance Dosage
    dabigatran etexilate mesylate 110 mg

    ATC: B01A B01AE B01AE07

  • It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.

    Dosage form: capsules, hard

    Active substance Dosage
    dabigatran etexilate mesylate 110 mg

    ATC: B01A B01AE B01AE07

  • It is used in children to treat blood clots and to prevent them from forming again.

    Dosage form: granules, coated

    Active substance Dosage
    dabigatran etexilate mesylate 172,95 mg

    ATC: B01A B01AE B01AE07

  • It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with non-valvular atrial fibrillation, and to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.

    Dosage form: capsules, hard

    Active substance Dosage
    dabigatran etexilate mesylate 172,95 mg

    ATC: B01A B01AE B01AE07

  • It is used in children to treat blood clots and to prevent them from forming again.

    Dosage form: granules, coated

    Active substance Dosage
    dabigatran etexilate mesylate 23,06 mg

    ATC: B01A B01AE B01AE07

  • It is used in children to treat blood clots and to prevent them from forming again.

    Dosage form: granules, coated

    Active substance Dosage
    dabigatran etexilate mesylate 34,59 mg

    ATC: B01A B01AE B01AE07

  • What is Pradaxa used for?": "It is used in children to treat blood clots and prevent them from forming again.", "How should I administer Pradaxa to my child?": "It should be taken twice a day, one dose in the morning and another at night, approximately every 12 hours. The medication should be mixed with apple juice or soft foods such as carrot puree, applesauce, or banana puree. It must not be mixed with milk or foods containing dairy products.", "When should my child not take Pradaxa?": "It should not be used if the child is allergic to the medication, if they have severely reduced renal function, if they have current bleeding, or if they have organ diseases that increase the risk of bleeding (such as ulcers or brain injuries). It should also not be taken if they have severely reduced hepatic function or if they are receiving certain other medications such as ketoconazole, itraconazole, cyclosporine, dronedarone, or products for hepatitis C.", "What side effects can Pradaxa have?": "The most common effects are related to bleeding, such as bruising, nosebleeds, or gastric reflux. Nausea, vomiting, diarrhea, indigestion, or skin changes may also occur. If the child experiences bleeding that does not stop, extreme weakness, paleness, dizziness, or unexplained swelling, you must consult a doctor immediately.", "What should I do if my child forgets a dose?": "If a dose is forgotten, it can be administered up to 6 hours before the next one. If there are less than 6 hours remaining until the next dose, the missed dose should be skipped. A double dose should not be administered to compensate.", "What precautions should I take if my child is having surgery?": "Pradaxa must be temporarily discontinued before a surgical procedure due to the increased risk of bleeding. It is essential to follow the doctor's instructions exactly regarding when to stop and when to resume it.", "How should I store the medication?": "It must be kept out of the sight and reach of children. Once the aluminum pouch containing the sachets is opened, the medication must be used within the following 6 months."

    Dosage form: granules, coated

    Active substance Dosage
    dabigatran etexilate mesylate 46,12 mg

    ATC: B01A B01AE B01AE07

  • What is Pradaxa used for?": "It is used in children to treat blood clots and to prevent them from forming again.", "How should I administer Pradaxa to my child?": "It should be taken twice a day, one dose in the morning and another at night, approximately every 12 hours. The medication should be administered before meals, mixed with apple juice or with soft foods such as carrot puree, applesauce, or banana puree. It must not be mixed with milk or foods containing dairy products.", "When should this medication not be used?": "It should not be used if the child is allergic to its components, if they have significantly reduced renal function, if they have current bleeding, or if they have organ diseases that increase the risk of serious bleeding (such as stomach ulcers or brain injuries). It should also not be used if the child has a natural tendency to bleed or if they are receiving other medications to prevent clots (such as warfarin, heparin, etc.), unless specifically instructed by a doctor.", "What should I do if my child misses a dose?": "If a dose is missed, it can be administered up to 6 hours before the next one. If there are less than 6 hours remaining until the next dose, the missed dose should be skipped. Do not administer a double dose to compensate.", "What are the side effects of Pradaxa?": "As an anticoagulant, the most common side effects are related to bleeding, such as bruising, nosebleeds, or bleeding in the stomach, intestine, or urinary tract. Other frequent effects include nausea, vomiting, indigestion, diarrhea, skin rash, or hair loss. You must consult a doctor immediately if you notice signs of excessive bleeding such as extreme weakness, paleness, dizziness, or headache.", "What other medications may interact with Pradaxa?": "The doctor must be informed if the child is taking medications for blood clotting, for fungal infections (such as ketoconazole), for heart rhythm, to prevent organ rejection, antivirals for hepatitis C or AIDS, anti-inflammatories (such as ibuprofen or diclofenac), or certain antidepressants and antibiotics.", "What precautions should I take if my child needs surgery?": "Pradaxa must be temporarily discontinued before a surgical procedure due to the increased risk of hemorrhage. It is essential to follow the doctor's instructions exactly regarding when to stop and when to resume it. If epidural or spinal anesthesia is used, inform the doctor immediately if the child experiences weakness or numbness in the legs."

    Dosage form: granules, coated

    Active substance Dosage
    dabigatran etexilate mesylate 57,65 mg

    ATC: B01A B01AE B01AE07

  • It is used in adults to prevent the formation of blood clots in the veins after knee or hip surgery. In children, it is used to treat blood clots and prevent them from reappearing.

    Dosage form: capsules, hard

    Active substance Dosage
    dabigatran etexilate mesylate 75 mg

    ATC: B01A B01AE B01AE07

  • It is used in adults to prevent the formation of blood clots in the veins after knee or hip surgery. In children, it is used to treat blood clots and prevent them from reappearing.

    Dosage form: capsules, hard

    Active substance Dosage
    dabigatran etexilate mesylate 75 mg

    ATC: B01A B01AE B01AE07

  • It is used in adults in emergency situations to rapidly reverse the effect of dabigatran, a medication that prevents blood clot formation. It is used in cases of potentially life-threatening or uncontrolled bleeding, or for emergency surgical interventions and procedures.

    Dosage form: solution for injection and for infusion

    Active substance Dosage
    idarucizumab 50 mg/ml

    ATC: V03A V03AB V03AB37

  • It helps adults with chronic obstructive pulmonary disease (COPD) breathe more easily by opening the airways and facilitating the flow of air in and out of the lungs.

    Dosage form: solution for inhalation

    Active substance Dosage
    olodaterol hydrochloride 0,0027 mg
    tiotropium bromide monohydrate 0,0031 mg

    ATC: R03A R03AL R03AL06

  • It is used to help people with chronic obstructive pulmonary disease (COPD) breathe more easily by opening the airways and facilitating the entry and exit of air from the lungs.

    Dosage form: powder for inhalation

    Active substance Dosage
    tiotropium bromide 0,018 mg

    ATC: R03B R03BB R03BB04

  • It helps people with chronic obstructive pulmonary disease (COPD) or asthma to breathe more easily by opening the airways.

    Dosage form: solution for inhalation

    Active substance Dosage
    tiotropium bromide 3,124 µg

    ATC: R03B R03BB R03BB04

  • It is used to help people with chronic obstructive pulmonary disease (COPD) breathe more easily by helping to open the airways.

    Dosage form: solution for inhalation

    Active substance Dosage
    olodaterol hydrochloride 0,0027 mg

    ATC: R03A R03AC R03AC19

  • What is Synjardy used for?": "It is used to treat type 2 diabetes in adults and children aged 10 years and older who have not achieved blood sugar control with metformin alone or with metformin combined with other medications. It can also be used as an alternative to taking empagliflozin and metformin separately.", "How should I take Synjardy?": "One tablet should be taken twice daily, swallowed whole with water. It is recommended to take it with food to reduce potential stomach discomfort.", "When should I not take this medication?": "Do not take it if you are allergic to its components, if you have type 1 diabetes, if you have severe kidney problems, liver problems, dehydration, serious infections (in the lungs, kidneys, or bronchial system), or if you have had diabetic precoma. It should also not be used if you have uncontrolled diabetes with symptoms such as nausea, vomiting, or rapid weight loss.", "What side effects can Synjardy cause?": "The most frequent side effects include low blood sugar levels (hypoglycemia), urinary tract infections, nausea, vomiting, diarrhea, or stomach pain. Fungal infections in the genital area, changes in taste, thirst, or constipation may also occur. In very rare cases, it can cause lactic acidosis (a serious complication) or diabetic ketoacidosis.", "What should I do if I experience serious side effects?": "You must stop taking Synjardy and contact a doctor or go to a hospital immediately if you experience symptoms of lactic acidosis (such as vomiting, abdominal pain, muscle cramps, extreme fatigue, difficulty breathing, or decreased body temperature) or diabetic ketoacidosis (such as excessive thirst, confusion, sweet-smelling breath, or rapid weight loss).", "Can I take other medications while using this treatment?": "You must inform your doctor if you take diuretics, insulin, diabetes medications (such as sulfonylureas), asthma medications, corticosteroids, anti-inflammatories (such as ibuprofen), blood pressure medications, or lithium. It is also important to notify them if you are going to receive an iodinated contrast injection for an X-ray.", "What precautions should I take regarding alcohol?": "You should avoid excessive alcohol consumption while taking this medication, as this can increase the risk of developing lactic acidosis."

    Dosage form: tablets, film-coated

    Active substance Dosage
    empagliflozin 12,5 mg
    metformin hydrochloride 1000 mg

    ATC: A10B A10BD A10BD20

  • It is used to treat type 2 diabetes in adults and children aged 10 years and older who cannot be controlled with metformin alone or with metformin combined with other medications. It also helps to reduce blood sugar levels and may help prevent heart disease.

    Dosage form: tablets, film-coated

    Active substance Dosage
    empagliflozin 5 mg
    metformin hydrochloride 1000 mg

    ATC: A10B A10BD A10BD20

  • It is used to treat type 2 diabetes in adults when the disease cannot be adequately controlled by diet, exercise, or other medications such as metformin or sulfonylureas alone.

    Dosage form: tablets, film-coated

    Active substance Dosage
    linagliptin 5 mg

    ATC: A10B A10BH A10BH05

  • It is used to treat high blood pressure in adults whose blood pressure is not controlled by amlodipine alone, or in patients who are already taking telmisartan and amlodipine separately and wish to combine them into a single tablet.

    Dosage form: tablets

    Active substance Dosage
    telmisartan 80 mg
    amlodipine besylate 10 mg

    ATC: C09D C09DB C09DB04